Response to McMullan et al, "Safety of dermatologic medications in pregnancy and lactation: An Update - Part I: Pregnancy," and Yaghi et al., "Safety of dermatologic medications in pregnancy and lactation: An Update - Part II: Lactation"

J Am Acad Dermatol. 2024 Apr 12:S0190-9622(24)00627-3. doi: 10.1016/j.jaad.2024.03.045. Online ahead of print.

¹ Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: katharina.shaw@pennmedicine.upenn.edu.

No abstract available

Keywords: lactation; maternal-fetal medicine; multidisciplinary care; pregnancy; rituximab; safety.

Publication types